NCT04723615

Brief Summary

The research is a study with methodological design. The validity, reliability and practicality of the Örebro Musculoskeletal System Screening Questionnaire-12 will be investigated. In this context, a questionnaire will be applied to the participants to take part in the study after the translation process is completed.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
319

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2020

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 18, 2020

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

January 17, 2021

Completed
9 days until next milestone

First Posted

Study publicly available on registry

January 26, 2021

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 18, 2023

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 18, 2024

Completed
Last Updated

January 20, 2022

Status Verified

January 1, 2022

Enrollment Period

3 years

First QC Date

January 17, 2021

Last Update Submit

January 18, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Orebro Musculoskeletal Screening Questionnaire-12

    It is a 12-item self-report questionnaire that aims to estimate a wide range of outcomes (severity of the problem, functional impairment, reporting status, cost and recovery time) in patients with acute and subacute work injury presenting with musculoskeletal pain involving the spine, upper and lower extremities.

    10 minutes

Interventions

It is a 12-item self-report questionnaire that aims to estimate the severity of the problem, functional impairment, reporting status, cost and recovery time in musculoskeletal problems.

A Visual Analogue Scale (VAS) is a measurement instrument that tries to measure a characteristic or attitude that is believed to range across a continuum of values and cannot easily be directly measured.

The Tampa Scale of Kinesiophobia that was developed in 1990 is a 17 item scale originally developed to measure the fear of movement related to chronic lower back pain.

The SF-12 is a self-reported outcome measure assessing the impact of health on an individual's everyday life. It is often used as a quality of life measure.

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Participants will be contacted via Google forms after the entire translation process of the questionnaire is completed. Participants will be 18-65 years and have any musculoskeletal problems (spine, upper or lower extremities).

You may qualify if:

  • Having any musculoskeletal problems (spine, upper or lower extremities)
  • Being in the age range of 18-65

You may not qualify if:

  • Pregnancy
  • Having of red flag signs.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Emel Taşvuran Horata

Afyonkarahisar, 03030, Turkey (Türkiye)

Location

Related Publications (1)

  • Tasvuran Horata E, Demir P, Yagci G, Erel S, Eken F, Gabel CP. The validity and reliability of the Turkish version of the 12-item Orebro musculoskeletal screening questionnaire (OMSQ-12-TR). Disabil Rehabil. 2023 Dec;45(25):4288-4295. doi: 10.1080/09638288.2022.2089918. Epub 2022 Jun 25.

Study Officials

  • EMEL TAŞVURAN HORATA

    Afyonkarahisar Health Science University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD; Assistant Professor

Study Record Dates

First Submitted

January 17, 2021

First Posted

January 26, 2021

Study Start

December 18, 2020

Primary Completion

December 18, 2023

Study Completion

December 18, 2024

Last Updated

January 20, 2022

Record last verified: 2022-01

Locations